Body Perception and Complex Regional Pain Syndrome
SDRC
2 other identifiers
observational
20
1 country
1
Brief Summary
In CRPS, perturbation of body image and pseudo-neglect syndrome of the body part affected are frequently found. Pain and sensory perturbation seems to modify the way patients perceived their body part affected. Does a local body image perturbation can affect the balanced of the global self-awareness?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2017
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2016
CompletedFirst Posted
Study publicly available on registry
September 15, 2016
CompletedStudy Start
First participant enrolled
January 6, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 27, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2017
CompletedJanuary 17, 2018
November 1, 2017
10 months
September 5, 2016
January 16, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Sensory testing
areas of the hand where spontaneous sensations were felt
day 1
Secondary Outcomes (1)
Neurological evaluation by questionary
day 1
Study Arms (2)
Patient
Patients suffering from CRPS of the lower limb Patients with sensory testing in the two hand and neuropsychological evaluation
Control
Healthy controls match by age, gender, Body Mass Index Healthy volunteers with sensory testing in the two hand and neuropsychological evaluation
Interventions
Eligibility Criteria
Patients suffering from CRPS of the lower limb and Healthy controls
You may qualify if:
- For patients:
- a diagnosis of CRPS of the lower limb according to the Budapest Criteria (men or women) For patients and control group
- Age ≥ 18 years
You may not qualify if:
- For patients and control group
- neurological disease with cerebral repercussion or not stabilized serious physical illness;
- psychotropic medication
- disorders related to the use of a psychoactive substance (abuse, dependence or withdrawal);
- For patients:
- Presence of an other pain disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Saint-Etienne
Saint-Etienne, 42055, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Christelle CREAC'H, MD
CHU SAINT-ETIENNE
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2016
First Posted
September 15, 2016
Study Start
January 6, 2017
Primary Completion
October 27, 2017
Study Completion
October 27, 2017
Last Updated
January 17, 2018
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share